Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005)

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 1, 2009, Pages 121-131

  Harper, Sam ^a   Lynch, John ^a,b,c   Meersman, Stephen C ^d   Breen, Nancy ^d   Davis, William W ^d   Reichman, Marsha C ^d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; POVERTY; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 58349115213     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0679     Document Type: Article

References (85)

1. Howe HL, Wu X, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/ Latino populations. Cancer 2006;107:1711-42.
2. Newman LA, Martin IK. Disparities in breast cancer. Curr Probl Cancer 2007;31:134-56.
3. Bigby J, Holmes MD. Disparities across the breast cancer continuum. Cancer Causes Control 2005;16:35-44.
4. U.S. Department of Health and Human Services. Healthy People 2010: understanding and improving health. Washington, DC: U.S. Department of Health and Human Services; 2000.
5. National Institutes of Health. The NCI strategic plan for leading the nation to eliminate the suffering and death due to cancer. Washington DC: National Cancer Institute U.S. Department of Health and Human Services; 2006.
6. Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control 2005;16:5-14.
7. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med 2002;162:1985-93.
8. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101:3-27.
9. SEER*Stat software (http://seer.cancer.gov/seerstat/) [computer program]. Version 6.4.4. Bethesda, MD: National Cancer Institute; 2008.
10. National Cancer Institute. Race recode changes 2007; Available at: http://seer.cancer.gov/seerstat/variables/seer/yr1973-2005/race--ethnicity/ [last accessed July 18, 2008].
11. Keppel KG, Pearcy JN. Measuring relative disparities in terms of adverse events. J Public Health Manag Pract 2005;11:479-83.
12. Keppel K, Pamuk E, Lynch J, et al. Methodological issues in measuring health disparities. Vital Health Stat 2005;2(121):1-16.
13. U.S. Department of Health and Human Services. Healthy People 2010: understanding and improving health. Washington (DC): U.S. Dept. of Health and Human Services; 2000.
14. Howe HL, Jamison M, Havener L, Chen VW, Reis L; NAACCR Collaborative Research Work Group. Site-specific comparison of Summary Stage 1977 and Summary Stage 2000 Coding.; available at: http://www.naaccr.org/filesystem/pdf/EOD-SS- All%20sites%20ALL.pdf [last accessed July 24, 2007].
15. National Cancer Institute. Measures of cancer survival. 2006 July 28; Available at: http://srab.cancer.gov/survival/measures.html [last accessed July 18, 2008].
16. Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Cronin K, Feuer E, Wesley M, Mariotto A, Scoppa S, Green D. Current estimates for 5 and 10 year relative survival. Technical report no. 2003-04. Bethesda, MD: National Cancer Institute, Statistical Research and Applications Branch; 2003. Available at: http://srab.cancer.gov/reports.
18. Singh GK, Miller BA, Hankey BF, Feuer EJ, Pickle LW. Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part I - all cancers among men. J Natl Cancer Inst 2002;94:904-15.
19. Singh GK, Miller BA, Hankey BF, Edwards BK. Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. Bethesda (MD): National Cancer Institute; 2003.
20. Singh GK, Siahpush M. Widening socioeconomic inequalities in US life expectancy, 1980-2000. Int J Epidemiol 2006;35:969-79.
21. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 2006;56:168-83.
22. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1973-2004. National Cancer Institute, Bethesda, MD 2007; Available at: http://seer.cancer.gov/csr/1975-2004/[last accessed July 18, 2008].
23. National Cancer Institute. Policy for calculating Hispanic mortality 2007; Available at: http://seer.cancer.gov/seerstat/variables/mort/ origin-recode-1990+/yr1969-2004/[last accessed July 18, 2008].
24. Harper S, Lynch J. Methods for measuring cancer disparities: a review using data relevant to Healthy People 2010 cancer-related objectives. NCI Cancer Surveillance Monograph Series no. 6. Washington DC: National Cancer Institute; 2006. http://seer.cancer.gov/publications/disparities/.
25. Harper S, Lynch J. Selected comparisons of measures of health disparities using databases containing data relevant to Healthy People 2010 cancer-related objectives. NCI Cancer Surveillance Monograph Series no. 7. Washington (DC): National Cancer Institute; 2007.
26. Kakwani N, Wagstaff A, van Doorslaer E. Socioeconomic inequalities in health: measurement, computation, and statistical inference. J Econometrics 1997;77:87-103.
27. Sen AK, Foster JE. On economic inequality. Expanded ed. Oxford: Clarendon Press; 1997.
28. Firebaugh G. The new geography of global income inequality. Cambridge (MA): Harvard University Press; 2003.
29. Keppel KG, Pearcy JN, Klein RJ. Measuring progress in Healthy People 2010. 2004; (PHS) 2004-1237.
30. Chiang CL. Standard error of the age-adjusted death rate. Vital Stat Spec Rep 1961;47(3):275-85.
31. Schootman M, Jeffe DB, Reschke AH, Aft RL. Disparities related to socioeconomic status and access to medical care remain in the United States among women who never had a mammogram. Cancer Causes Control 2003;14:419-25.
32. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13.
33. Ross JS, Bradley EH, Busch SH. Use of health care services by lower-income and higher-income uninsured adults. JAMA 2006;295:2027-36.
34. Williams BA, Lindquist K, Sudore RL, Covinsky KE, Walter LC. Screening mammography in older women: effect of wealth and prognosis. Arch Intern Med 2008;168:514-20.
35. Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev 2002;11:59-71.
36. Bailey TM, Delva J, Gretebeck K, Siefert K, Ismail A. A systematic review of mammography educational interventions for low-income women. Am J Health Promot 2005;20:96-107.
37. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670-4.
38. Breen N, Cronin KA, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer 2007;109:2405-9.
39. Jemal A, Ward E, Thun M. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007;9:R28.
40. Berry DA, Ravdin PM. Breast cancer trends: a marriage between clinical trial evidence and epidemiology. J Natl Cancer Inst 2007;99:1139-41.
41. Glass AG, Lacey JV, Jr., Carreon JD, Hoover RN. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007;99:1152-61.
42. Kerlikowske K, Miglioretti DL, Buist DSM, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 2007;99:1335-9.
43. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
44. Sturmer T, Manson JE. Estrogens and breast cancer: does timing really matter? J Clin Epidemiol 2004;57:763-5.
45. Wiseman RA. Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly. J Clin Epidemiol 2004;57:766-72.
46. Friedman-Koss D, Crespo C, Bellantoni MF, Andersen RE. The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994. Menopause 2002;9:264-72.
47. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 2007;110:876-84.
48. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005;97:439-48.
49. Hirschman J, Whitman S, Ansell D. The black:white disparity in breast cancer mortality: the example of Chicago. Cancer Causes Control 2007;18:323-33.
50. Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare System. Cancer 2003;98:894-9.
51. Chu KC, Tarone RE, Brawley OW. Breast cancer trends of black women compared with white women. Arch Fam Med 1999;8:521-8.
52. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 2005;23:6639-46.
53. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med 1998;128:729-36.
54. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 1993;329:326-31.
55. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates - separating factors that affect diagnosis from factors that affect treatment. Cancer 2003;97:2853-60.
56. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002;94:490-6.
57. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49-56.
58. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 2006;24:1357-62.
59. Banerjee M, George J, Yee C, Hryniuk W, Schwartz K. Disentangling the effects of race on breast cancer treatment. Cancer 2007.
60. Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study. Ethn Dis 1999;9:111-25.
61. Smedley BD, Stith AY, Nelson AR. Unequal treatment: confronting racial and ethnic disparities in health care. Washington (DC): National Academy Press; 2003.
62. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005;294:1765-72.
63. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-502.
64. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007;109:1721-8.
65. Cross CK, Harris J, Recht A. Race, socioeconomic status, and breast carcinoma in the U.S.: what have we learned from clinical studies. Cancer 2002;95:1988-99.
66. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and White American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 2006;24:1342-9.
67. Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA 2005;294:2879-88.
68. Krieger N, Davey Smith G. "Bodies count", and body counts: social epidemiology and embodying inequality. Epidemiol Rev 2004;26:92-103.
69. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology 1997;8:621-8.
70. National Center for Health Statistics. Health, United States, 2006 with Chartbook on Trends in the Health of Americans. Hyattsville (MD): National Center for Health Statistics; 2006.
71. Field TS, Buist DS, Doubeni C, et al. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr 2005;35:88-95.
72. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl JMed 2005;353:1784-92.
73. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006;Art. No.: CD001877. DOI: 10.1002/14651858.CD001877.pub2.
74. Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol 2004;33:43-55.
75. Dignam JJ. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr 2001;30:36-43.
76. Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007;25:1683-90.
77. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
78. Heck KE, Wagener DK, Schatzkin A, Devesa SS, Breen N. Socioeconomic status and breast cancer mortality, 1989 through 1993: an analysis of education data from death certificates. Am J Public Health 1997;87:1218-22.
79. Wagener DK, Schatzkin A. Temporal trends in the socioeconomic gradient for breast cancer mortality among US women. Am J Public Health 1994;84:1003-6.
80. Heck KE, Pamuk ER. Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol 1997;145:366-72.
81. Steenland K, Henley J, Thun M. All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. Am J Epidemiol 2002;156:11-21.
82. Steenland K, Henley J, Calle E, Thun M. Individual- and area-level socioeconomic status variables as predictors of mortality in a cohort of 179,383 persons. Am J Epidemiol 2004;159:1047-56.
83. Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst 2007;99:1384-94.
84. Kinsey T, Jemal A, Liff J, Ward E, Thun M. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst 2008;100:1003-12.
85. Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman ME. An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by area-socioeconomic position and race-ethnicity, 1992-2004. Am J Epidemiol 2008;167:889-99.